author-photo

Bengt Gustavsson

Novartis

8

Papers

1366

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec).

2010 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (4)
Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis

2006 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (189)
Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.

2005 Cancer
Show All
- Source
- Cite
- Save
Citations (1034)
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

2003 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (37)
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia

2002 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (3)
P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

2000 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (86)